Supported by Abenex, the Inlog Group is continuing its international expansion with the acquisition of Belgium’s Moonchase, publisher of online laboratory management software.

Welcome to the Moonchase team !

[Lyon, 10/05/2023] – Accompanied by Abenex since 2020, the Inlog Group, a major software publisher in the Laboratory and Blood sectors, has made its third acquisition taking over the Belgian company Moonchase and its online laboratory management software. This external growth reflects the Inlog Group’s determination to pursue its international expansion. Already very present abroad with its EdgeBlood ,blood transfusion management software solution, Inlog is expanding its network in Benelux with its EdgeLab offering for hospital laboratories. Over the past 12 months, the Inlog Group has already demonstrated its ambition to become a major player in the field of laboratory quality and certification with the acquisition of Viskali and Silk (Ubilab).

With a bunch of employees and €1 million in recurring revenues, Moonchase is renowned for its advanced, versatile LMS (Laboratory Management System) available in five languages: French, English, German, Spanish and Dutch. This acquisition enables Inlog to better serve analytical laboratories around the world by offering a complete, multilingual solution for managing their laboratory operations.

 

 

With Moonchase’s Labo en Ligne software, Inlog has a web-based, multilingual LMS.

Moonchase’s laboratory management software meets the diverse needs of analysis laboratories thanks to its user-friendly, customisable interface and advanced features for efficient management of analysis results. Its web and mobile interfaces guarantee mobile access and offer maximum flexibility for healthcare professionals and patients.

“We are delighted to welcome Moonchase to the Inlog Group,” said David Kalfon, President of Inlog. “This acquisition reinforces our commitment to provide leading-edge solutions to analytical laboratories worldwide. With Labo en Ligne, Moonchase’s LIMS now integrated into our portfolio, we are able to meet our customers’ needs in a more comprehensive and multilingual way.”

This acquisition is a significant step in the Inlog Group’s international expansion strategy, strengthening its position as a major industry player in the provision of medical IT solutions for healthcare facilities. The Group thus continues to work towards improving healthcare on a global scale by offering innovative technological tools for more efficient management of resources and operations.

About Inlog :

Created in the early 1990’s, In Log S.A.S is one of the main French editors in the field of medical software for medical analysis laboratories, hospitals and blood transfusion centers.

In Log S.A.S is the European leader in the area of blood transfusion information systems and a major player in the LIS (Laboratory Information Systems) market.

For more information about Inlog and its solutions, please visit the company’s website at www.inlog.com.

Follow our news on our LinkedIn page.